ALK-positive non-small cell lung cancer (NSCLC) is a subtype of lung cancer characterised by a genetic mutation in the anaplastic lymphoma kinase (ALK) gene. Several first-line treatments are available

One of the most common and fatal types of cancer in the world continues to be lung cancer. The most prevalent form of lung cancer, non-small cell lung cancer (NSCLC), is characterised by its heterogeneity,